Pages

Monday, July 09, 2007

Mitchell Goes To Washington

Tip of the cap to today's PE Week Wire (can't link to an email but go to PE Hub) for this one. Familiar face Kate Mitchell, managing director at Scale Venture Partners (formerly BA Venture Partners),will be representing the PE industry Wednesday at a congressional hearing on the proposed carried interest legislation.

While she primarily invests in software and business services companies she's also walked within life sciences circles from time to time, including investments in Acusphere and Songbird.

The very personable Mitchell serves on the board of directors of the National Venture Capital Association. Also testifying before the Senate Finance Committee will be representatives from Treasury, the SEC, the Congressional Budget Office and Mark Gergen, a University of Texas Law School professor, who, according to PE Week Wire, will argue in favor of taxing carried interest at 35% rather than 15%

1 comment:

Billy said...

Most ballplayers today are taking homeopathic hgh oral spray because it's safe, undetectable, and legal for over the counter sales. As time goes on it seems it might be considered as benign a performance enhancer as coffee, aspirin, red bull, chewing tobacco, and bubble gum.